Trial intelligence / Profile preview

Anti-CD146 Autoantibodies for Diagnosis of Silica-Related Pulmonary Diseases

NCT07376291Not yet recruiting

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Jun 2026
Primary completion
Jun 2028
01

Overview

Trial (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Prevalence ratio of AACD146 between the exposed and non-exposed groups. Planned start Jun 2026; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07376291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07376291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call